# Infectious Diseases Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Florence Nightingale (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI004-SYN-TD
- Date: 1858-03-02
- Fictional facility: St. Posthumous Health Center
- Fictional author: Isobel Marchetti, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Daniel Abernathy, MD, Infectious Diseases
- Urgency: Routine, within two weeks

## Referral question

Suspected post-infectious ME/CFS in a 37-year-old nurse administrator who was treated for brucellosis abroad. Before we attribute her symptoms to ME/CFS, please assess for relapsed or focal brucellosis or another persisting infection. **S**

## Questions for the consultant

1. Is there any clinical or laboratory evidence of relapsed brucellosis or a focal complication such as spondylitis, sacroiliitis, or endocarditis?
2. Would repeat Brucella serology or blood cultures help now?
3. Is any other infection related to her field-hospital work worth excluding?
4. Is there any role for further antibiotics?

## Pertinent history

Nearly three years ago, while leading nurses at an overseas field hospital, she had a severe febrile illness with sweats and aches; a Brucella agglutination titer there was reported positive and she completed six weeks of doxycycline and rifampin, with the fever resolving. Since then she has had debilitating fatigue worsened by activity, post-exertional malaise lasting days, unrefreshing sleep, and cognitive difficulty, worse after an intense period of work last year. She is housebound most days. Today she is afebrile; a ten-minute standing test shows a heart rate rise of 26/min without hypotension. No spinal or joint tenderness and no liver or spleen enlargement. The NICE exclusion tests, including ESR and CRP, were drawn today. **S**

- Florence Nightingale was born on May 12, 1820, in Florence, Italy, where her parents were on a European tour; her elder sister, Frances Parthenope, was born in 1819. **D**
- In October 1854 she led a party of thirty-eight nurses from London to the British military hospitals at Scutari, arriving in November 1854. **D**
- In May 1855, a few days after crossing to Balaclava to inspect the hospitals in the Crimea, she fell ill with what the army doctors called Crimean fever. She was carried to the Castle Hospital, was dangerously ill and, by her own later account, very near to death; she was reported out of danger on May 24 and made a slow and painful recovery before returning to work at Scutari. **D**
- Modern writers have interpreted her Crimean fever as brucellosis and her long later illness as chronic brucellosis. **R**
- She returned to England in the summer of 1856, emaciated and tense, and pressed for a royal commission on the health of the army, which was established in 1857. **D**
- In 1857, while working on her report for the commission, she was overworking and in failing health; she sought rest at Malvern in August and September and again in December, but would not stop working. She collapsed with cardiac symptoms so severe that it was thought she would die, and afterward suffered from nausea, insomnia, and palpitations. On her doctors' orders she took to her bed or couch but continued to work, the beginning of about twenty years of invalidism. **D**
- Her own 830-page report, Notes on Matters Affecting the Health, Efficiency, and Hospital Administration of the British Army (1858), used statistical evidence to show how much army mortality was due to conditions in the hospitals. She was elected to the Statistical Society, the first woman member. **D**
- Her prolonged illness has also been read retrospectively as what is now called myalgic encephalomyelitis/chronic fatigue syndrome, while other writers have proposed neurasthenia, a psychosomatic illness, or illness used to secure time for work. **R**

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: Hemoglobin: 12.9 g/dL; White cell count: 5.8 10*3/uL; Platelets: 246 10*3/uL; Sodium: 139 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.72 mg/dL; eGFR: 110 mL/min/1.73 m²; Glucose: 86 mg/dL; Calcium: 9.3 mg/dL; Albumin: 4.3 g/dL; ALT: 16 U/L; AST: 19 U/L; Alkaline phosphatase: 68 U/L; Total bilirubin: 0.6 mg/dL; Phosphate: 3.6 mg/dL; ESR: 8 mm/h; CRP: 1.2 mg/L; TSH: 1.9 mIU/L; HbA1c: 5.1%; Ferritin: 48 ng/mL; Tissue transglutaminase IgA: 1 U/mL; Creatine kinase: 92 U/L; Morning cortisol: 14.2 ug/dL; Vitamin B12: 410 pg/mL; Folate: 12.4 ng/mL; 25-hydroxyvitamin D: 17 ng/mL (low); PHQ-9: 8; GAD-7: 5; PROMIS fatigue T-score: 71; PROMIS physical function T-score: 32; Pain score (0 to 10): 4. All results are synthetic.

BP 104/66 mmHg; pulse 78 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 55 kg; BMI 19 kg/m². All vital signs are synthetic.

## Current medications

- Acetaminophen 500 mg oral tablet, one to two tablets by mouth every 6 hours as needed for muscle pain or headache, no more than 3 g a day **S**

## Plan so far

- Diagnose ME/CFS by clinical criteria after exclusion tests, explain that it is a real illness with no diagnostic test, and give her a written care and support plan, including a flare plan. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024) **S**
- Energy management led by the patient: an activity and symptom diary, planned rest before and between tasks, work broken into short blocks, and heart-rate awareness; no graded exercise therapy or fixed increases in activity. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024); Grach SL, et al. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc 2023;98(10):1544-1551 (2023) **S**
- Orthostatic intolerance measures: 2 to 2.5 L of fluid a day, more salt with meals, waist-high compression garments, and tasks done seated or reclined; repeat the standing test at six months. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Grach SL, et al. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc 2023;98(10):1544-1551 (2023) **S**
- Sleep, pain, and cognitive symptom care: a regular sleep window with rest periods kept short, acetaminophen as needed, no sedatives or opioids, and memory aids for work. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024) **S**
- Review the care plan at every visit, with PHQ-9, PROMIS fatigue and physical function scores, and a pain score; primary care review at least yearly and more often while the plan is new. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021) **S**
- Workplace adjustments: home working, a reclined workstation, flexible hours, and meetings by video or at her home. Guideline: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024) **S**
